
|Articles|March 1, 2017
- Pharmaceutical Executive-03-01-2017
- Volume 37
- Issue 3
Pharmaceutical Executive, March 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive March 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 9 years ago
Big Data: Is It Crunch Time for Pharma?about 9 years ago
Setting Sights on the Smart Supply Chainabout 9 years ago
Global Pharma Deals with US Trade Overhaulsabout 9 years ago
Precision Medicine and Big Dataabout 9 years ago
Country Report: IrelandNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Asembia ASX26: Adjusting Strategies to Adapt to an Uncertain Global Political and Regulatory Market
2
Which Supply Chains are Most Exposed by Disruptions in The Strait of Hormuz?
3
Asembia AXS26 Summit: The Future of High-Cost Specialty Drugs
4
Pharmaceutical Executive Daily: FDA Approves Breztri
5




